356 related articles for article (PubMed ID: 30151927)
21. High YBX1 expression indicates poor prognosis and promotes cell migration and invasion in nasopharyngeal carcinoma.
Zhou LL; Ni J; Feng WT; Yao R; Yue S; Zhu YN; Tang HY; Lv LY; Feng JF; Zhu WG
Exp Cell Res; 2017 Dec; 361(1):126-134. PubMed ID: 29024700
[TBL] [Abstract][Full Text] [Related]
22. High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma.
Zhou J; Zhang J; Xu M; Ke Z; Zhang W; Mai J
PLoS One; 2019; 14(4):e0215299. PubMed ID: 30973923
[TBL] [Abstract][Full Text] [Related]
23. TGF-? regulates the ERK/MAPK pathway independent of the SMAD pathway by repressing miRNA-124 to increase MALAT1 expression in nasopharyngeal carcinoma.
Du M; Chen W; Zhang W; Tian XK; Wang T; Wu J; Gu J; Zhang N; Lu ZW; Qian LX; Fei Q; Wang Y; Peng F; He X; Yin L
Biomed Pharmacother; 2018 Mar; 99():688-696. PubMed ID: 29710466
[TBL] [Abstract][Full Text] [Related]
24. Vimentin is a crucial target for anti-metastasis therapy of nasopharyngeal carcinoma.
Wang W; Yi M; Zhang R; Li J; Chen S; Cai J; Zeng Z; Li X; Xiong W; Wang L; Li G; Xiang B
Mol Cell Biochem; 2018 Jan; 438(1-2):47-57. PubMed ID: 28744809
[TBL] [Abstract][Full Text] [Related]
25. TEL2 suppresses metastasis by down-regulating SERPINE1 in nasopharyngeal carcinoma.
Sang Y; Chen MY; Luo D; Zhang RH; Wang L; Li M; Luo R; Qian CN; Shao JY; Zeng YX; Kang T
Oncotarget; 2015 Oct; 6(30):29240-53. PubMed ID: 26335051
[TBL] [Abstract][Full Text] [Related]
26. AIMP2-DX2 Promotes the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma Cells.
Cao Q; Zhang J; Zhang T
Biomed Res Int; 2018; 2018():9253036. PubMed ID: 29854811
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-577/EIF5A2 axis suppressed the proliferation of DDP-resistant nasopharyngeal carcinoma cells by blocking TGF-β signaling pathway.
Wu R; Zhong Q; Liu H; Liu S
Chem Biol Drug Des; 2023 Oct; 102(4):815-827. PubMed ID: 37500510
[TBL] [Abstract][Full Text] [Related]
28. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression.
Su Y; Yu QH; Wang XY; Yu LP; Wang ZF; Cao YC; Li JD
BMC Cancer; 2017 Jul; 17(1):477. PubMed ID: 28693517
[TBL] [Abstract][Full Text] [Related]
29. Chemically synthesized cinobufagin suppresses nasopharyngeal carcinoma metastasis by inducing ENKUR to stabilize p53 expression.
Hou R; Liu X; Yang H; Deng S; Cheng C; Liu J; Li Y; Zhang Y; Jiang J; Zhu Z; Su Y; Wu L; Xie Y; Li X; Li W; Liu Z; Fang W
Cancer Lett; 2022 Apr; 531():57-70. PubMed ID: 35114328
[TBL] [Abstract][Full Text] [Related]
30. Role of the TGFβ/PDCD4/AP-1 Signaling Pathway in Nasopharyngeal Carcinoma and Its Relationship to Prognosis.
Ma J; Xuan SH; Li Y; Zhang ZP; Li XH
Cell Physiol Biochem; 2017; 43(4):1392-1401. PubMed ID: 29017171
[TBL] [Abstract][Full Text] [Related]
31. Blocking PI3K/Akt signaling attenuates metastasis of nasopharyngeal carcinoma cells through induction of mesenchymal-epithelial reverting transition.
Jiang H; Gao M; Shen Z; Luo B; Li R; Jiang X; Ding R; Ha Y; Wang Z; Jie W
Oncol Rep; 2014 Aug; 32(2):559-66. PubMed ID: 24889918
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of Nogo receptor 3 (NgR3) correlates with poor prognosis and contributes to the migration of epithelial cells of nasopharyngeal carcinoma patients.
He JY; Han P; Zhang Y; Liu YD; Song SJ; Feng GK; An Y; Zhou AJ; Wang HB; Yuan L; Lin ZR; Xia TL; Li MZ; Liu YM; Huang XM; Zhang H; Zhong Q
J Mol Med (Berl); 2018 Apr; 96(3-4):265-279. PubMed ID: 29327067
[TBL] [Abstract][Full Text] [Related]
33. TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt/β-catenin signaling pathway and promoting the epithelial mesenchymal transition.
Liu SL; Lin HX; Lin CY; Sun XQ; Ye LP; Qiu F; Wen W; Hua X; Wu XQ; Li J; Song LB; Guo L
Cancer Lett; 2017 Aug; 402():117-130. PubMed ID: 28583847
[TBL] [Abstract][Full Text] [Related]
34. Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signaling.
He QY; Yi HM; Yi H; Xiao T; Qu JQ; Yuan L; Zhu JF; Li JY; Wang YY; Li LN; Feng J; Lu SS; Xiao ZQ
Oncotarget; 2015 Jun; 6(18):16422-36. PubMed ID: 25915430
[TBL] [Abstract][Full Text] [Related]
35. (S,R)3-(4-Hydroxyphenyl)-4,5-Dihydro-5-Isoxazole Acetic Acid Methyl Ester Inhibits Epithelial-to-Mesenchymal Transition Through TGF-β/Smad4 Axis in Nasopharyngeal Carcinoma.
Chen Q; Wang Y; Li F; Cheng X; Xiao Y; Chen S; Xiao B; Tao Z
Anticancer Agents Med Chem; 2022; 22(6):1080-1090. PubMed ID: 34229595
[TBL] [Abstract][Full Text] [Related]
36. Hippo pathway contributes to cisplatin resistant-induced EMT in nasopharyngeal carcinoma cells.
Li S; Zhang X; Zhang R; Liang Z; Liao W; Du Z; Gao C; Liu F; Fan Y; Hong H
Cell Cycle; 2017; 16(17):1601-1610. PubMed ID: 28749195
[TBL] [Abstract][Full Text] [Related]
37. SPLUNC1 is associated with nasopharyngeal carcinoma prognosis and plays an important role in all-trans-retinoic acid-induced growth inhibition and differentiation in nasopharyngeal cancer cells.
Zhang W; Zeng Z; Wei F; Chen P; Schmitt DC; Fan S; Guo X; Liang F; Shi L; Liu Z; Zhang Z; Xiang B; Zhou M; Huang D; Tang K; Li X; Xiong W; Tan M; Li G; Li X
FEBS J; 2014 Nov; 281(21):4815-29. PubMed ID: 25161098
[TBL] [Abstract][Full Text] [Related]
38. Upregulated METTL3 in nasopharyngeal carcinoma enhances the motility of cancer cells.
Liu ZF; Yang J; Wei SP; Luo XG; Jiang QS; Chen T; Gong YQ
Kaohsiung J Med Sci; 2020 Nov; 36(11):895-903. PubMed ID: 32668092
[TBL] [Abstract][Full Text] [Related]
39. Reduced CTGF expression promotes cell growth, migration, and invasion in nasopharyngeal carcinoma.
Zhen Y; Ye Y; Yu X; Mai C; Zhou Y; Chen Y; Yang H; Lyu X; Song Y; Wu Q; Fu Q; Zhao M; Hua S; Wang H; Liu Z; Zhang Y; Fang W
PLoS One; 2014; 8(6):e64976. PubMed ID: 23755163
[TBL] [Abstract][Full Text] [Related]
40. CFTR is a potential marker for nasopharyngeal carcinoma prognosis and metastasis.
Tu Z; Chen Q; Zhang JT; Jiang X; Xia Y; Chan HC
Oncotarget; 2016 Nov; 7(47):76955-76965. PubMed ID: 27769067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]